Amgen, AMD, Vistra Lead Today's Analyst Moves

Three names dominate Thursday's analyst tape: AMGN, AMD, and VST.

Amgen gets a triple lift. Three separate firms raised their price targets on the biotech. RBC Capital moved its Buy target from $430 to $470. Wells Fargo lifted its Hold target by the same $30 to $460. Truist Securities also bumped to $398. All three acted on the same day, suggesting recent pipeline or earnings news is reshaping the consensus view.

AMD targets climb again. Truist's William Stein lifted his Buy target from $594 to $605. RBC's Srini Pajjuri held his view at Hold with a $540 target, unchanged. The stock carries a Buy-heavy consensus of 43 Buy ratings against just 10 Holds, with zero Sells.

Vistra gets cut. Keybanc downgraded the power utility from Buy to Hold. No new price target was provided. That is the standout negative move today and bucks the broadly bullish tone elsewhere on the tape.

Lockheed Martin initiated at Buy. Guggenheim kicked off coverage of LMT with a $735 target. The defence sector has attracted fresh analyst attention amid ongoing geopolitical uncertainty.

EXPD saw Truist raise its Hold target from $175 to $200. FANG got a Truist Buy target lift to $232. AME and ANET each received modest target increases from RBC Capital and Truist respectively.

BALL was the other negative note. Truist trimmed its Buy target on the packaging company from $78 to $76.